The Latest Cardiac and Vascular News
BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating complex, life-threatening conditions, including stroke, aneurysms, and arteriovenous malformations, today announced the appointment of Jeffrey Sachs as the Company’s Chief Legal & Compliance Officer. Jeffrey Sachs joins the Balt […]
Renova Therapeutics Inc, a leader in the development of gene therapies for cardiovascular diseases and diabetes, announced the appointment of Dr. Vijay Mahant to the position of CEO, effective as of Sept. 16, 2021. CARLSBAD, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) — Dr. Mahant brings a wealth of knowledge and […]
SILVER SPRING, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (the “Company”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the closing of the previously announced private investment in public equity (PIPE) financing. […]
HANGZHOU, China, Dec. 7, 2021 /PRNewswire/ — Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its acquisition of Cardiovalve Ltd. (Cardiovalve), a pioneering transcatheter mitral and tricuspid valve treatment company on December 7th, 2021. Venus Medtech will acquire 100% equity interest and corresponding equity […]
Company plans construction of a new commercial manufacturing facility Prairie Village, KS – December 8, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that the City Council of Olathe, KS has approved a development agreement […]
BEDMINSTER, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (LNC) platform delivery technology, today announced the appointment of Thomas Hoover to the newly created position of Chief Business Officer. […]
Acquisition expands Integer’s cardiovascular and neurostimulation product portfolio through broadened product offering and addition of low-cost manufacturing capacity PLANO, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer today announced the close of its acquisition of Oscor, Inc., a privately-held […]
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 30, 2021 it granted stock options to purchase an aggregate of 143,500 shares of common stock to 9 new employees, whose employment commenced in November 2021, as a material inducement to […]
Former Medtronic Executive Brings Significant Experience in Cardiac and Remote Patient Monitoring to Help Deliver Qardio’s Mission to Transform Cardiac and Chronic Care AMSTERDAM & SAN FRANCISCO–(BUSINESS WIRE)–Qardio, Inc. (“Qardio” or “Company”), a medical technology company that operates at the intersection of cardiology and remote patient monitoring, today announced the Company’s […]
Clinical, science, and natural products industry experts to advance Company’s research, clinical studies, and product development strategies SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Calroy Health Sciences, a company dedicated to developing innovative natural solutions to optimize cardiovascular health, today announced the establishment of a science and medical advisory board comprised of leading researchers and […]
